China Pharma Holdings, Inc. Announces Second Quarter 2008 Financi... ( NEW YORK and HAIKOU CITY China Au...)

China Pharma Holdings, Inc. Announces Second Quarter 2008 Financial Results

Date:8/6/2008

NEW YORK and HAIKOU CITY, China, Aug. 6 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI) which develops, manufactures, and markets generic and branded bio-pharmaceutical products in China, today announced its financial results for the second quarter of 2008.

Second Quarter 2008 Highlights

-- Second quarter revenues increased 31.6% to $11.28 million

-- Net income increases 21.32% to $4.04 million

-- Sales of bio-product Cerebroprotein increased 125.26% year-over-year.

-- EPS was $0.10, up 15.92% year-over-year

First Half Year 2008 Highlights

-- Revenue increased 45.51% for the same period in 2007 to $23 million

-- Net income was $8.23 million, up 44.34% for the same period in 2007

-- EPS was $0.22, up 39.25% for the same period in 2007

-- Company completed capital raise of $10 million

-- Company launched Bumetanide injection in June 2008

Second Quarter of 2008 Results (Unaudited):

Revenues for the second quarter of 2008 increased 31.6% to $11.3 million compared to $8.6 million for the same quarter in 2007. The growth in revenues was primarily due to organic growth of the existing product portfolio and increasing overall enhanced marketing efforts.

Quarterly gross profit for the second quarter of 2008 was $6 million, compared to $3.9 million for the same period last year, with gross margins of 52.8% and 45.5% respectively. The increase of gross margins was favorably impacted by the increase of revenues of our high margin products. The increase in gross margin reflected the management's clear vision of product selection and development.

Total operating expenses for the three months ended June 30, 2008 were $1.6 million compared to $0.53 million for the same period last year, mainly due to increased revenue and operating expenses. Selling expenses for the period increased to approximately $0.46 million from
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10
Related biology technology :

1. China Biologic Products Begins Annual Maintenance of its Production Facilities
2. China Pharma Holdings, Inc. to Host Second Quarter 2008 Earnings Conference Call at 10 a.m. EDT Wednesday August 6, 2008
3. China Biologic Products Establishes Audit Committee and Appoints Three New Independent Directors to Board of Directors
4. Global Stem Cell Forum in China Showcases Cutting Edge Research, Focuses on New Findings for iPS Cells
5. China Medical Technologies Adjusts Conversion Rate of Convertible Notes
6. China-Biotics, Inc. Files Application for Nasdaq Listing
7. China Biologic Products Honored with the Advanced Technology Certification for Foreign-Funded Enterprises
8. China-Biotics, Inc. Announces Appointment of New Transfer Agent Effective August 15, 2008
9. China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results
10. WuXi PharmaTech (NYSE: WX) Named the Most Innovative Company in China and CEO Dr. Li the Most Innovative Leader of Chinese Enterprises
11. China Biologic Products Begins Operation of its Newly Constructed Plasma Collection Station in Qi He County, Shandong Province

Post Your Comments:

China Pharma Holdings, Inc. Announces Second Quarter 2008 Financi...( NEW YORK and HAIKOU CITY China Au...)